10 likes | 84 Views
This study presents detailed prevalence data of antibiotic resistance genes in Enterobacteriaceae strains, such as E. coli, K. oxytoca, K. pneumoniae, and P. mirabilis. The findings shed light on the distribution of resistance mechanisms and their impact on public health.
E N D
Prevalence:0.85% E. coli: 35/3116 (1.12%) CMY-2 33 (1.05%) CMY-54 1 (0.03%) CMY-55 1 (0.03%) DHA-1 1 (0.03%) K. oxytoca: CMY-2 1/152 (0.6%) K. pneumoniae: CMY-2 1/330 (0.3%) P. mirabilis: CMY-2 4/473 (0.84%) Prevalence: 0.6% E. coli: CMY-2 17/3145 (0.54%) K. oxytoca: CMY-2 1/22 (4.55%) K. pneumoniae: CMY-2 1/65 (1.54%) P. mirabilis: CMY-2 6/212 (2.83%) Prevalence: 0.66% E. coli: 23/2402 (0.95%) CMY-2 21 (0.87%) CMY-4 1 (0.04%) CMY-7 1 (0.04%) P. mirabilis: CMY-2 3/167 (1.8%) Prevalence: 0.41% C. koseri: CMY-2 1/41 (2.4%) E. coli: 14/2987 (0.47%) CMY-2 13 (0.44%) DHA-1 1 (0.03%) P. mirabilis: CMY-2 2/352 (0.57%) P. penneri: CMY-2 1/1 Prevalence: 0.92% C. koseri: 3/34 (8.8%) DHA-1 2 (0.06%); ACC-1 + ACT-2 1 (0.03%) E. coli: 136/ 16059 (0.84%) ACC-1 3 (0.02%) CMY-2 96 (0.6%) CMY-4 1 CMY-27 2 CMY-48 1 DHA-1 30 (0.18%) DHA-6 1 FOX-3 1 VIM-1 1 K. oxytoca: 13/400 (3.25%) DHA-1 5 (1.25%) VIM-1 8 (2%) K. pneumoniae: 58/2412 (2.4%) ACC-1 3 (0.12%) CMY-2 3 (0.12%) CMY-56 2 (0.08%) DHA-1 48 (2%) VIM-1 3 (0.12%) P. mirabilis: 24/1710 (1.4%) ACC-1 3 (0.17%) CMY-2 18 (1.05%) DHA-1 3 (0.17%) Salmonella: DHA-1 1/28 (3.5%) E. cloacae: 6/209 (1.4%) VIM-1 4 (1.9%) DHA-7 + VIM-1 2 (0.95%) Prevalence:0.61% E. coli: 81/9539 (0.85%) CMY-2 79 (0.82%) CMY-43 1 (0.01%) DHA-1 1 (0.01%) K. pneumoniae: CMY-60 1/199 (0.5%) P. mirabilis: CMY-2 1/301 (0.33%) Prevalence:0.63% E. coli: 20/2804 (0.71%) CMY-2 18 (0.64%) DHA-1 2 (0.06%) K. pneumoniae: 3/343 (0.87%) CMY-2 1/343 (0.3%) DHA-1 2 (0.6%) P. mirabilis: CMY-2 4/372 (1%) Prevalence: 0% Prevalence: 0.5% E. coli: 81/12962 (0.62%) CMY-2 79 (0.60%) DHA-1 2 K. pneumoniae: 13/1651 (0.84%) CMY-2 5 (0.36%) DHA-1 3 (0.12%) VIM-1 5 (0.3%) K. oxytoca: 3/65 (4.61%) VIM-1 2 (3.07%) IMP-28 1 (1.53%) P. mirabilis: CMY-2 10/1414 (0.7%) E. cloacae: VIM-1 5/85 (5.88%) Prevalence: 0.47% E. coli: CMY-2 2/203 (0.99%) Prevalence: 0.47% E. coli: 12/1431 (0.83%) CMY-2 8 (0.56%) CMYt 3 (0.21%) DHA-1 1 (0.07%) K. pneumoniae: 15/237 (6.3%) CMY-2 1 (0.42%) DHA-1 10 (4.2%) DHAt 3 (1.3%) CMY-2 + DHA-1 1 (0.42%) P. mirabilis: CMY-2 2/204 (0.98%) Prevalence: 0.45% E. coli: 19/4360 (0.43%) CMY-2 17 (0.4%) CMY-57 1 (0.02%) DHA-1 1 (0.02%) K. pneumoniae: 7/785 (0.89%) CMY-2 5 (0.63%) DHA-1 2 (0.25%) IMP-22 9 (1.14%) VIM-1 1 (0.12%) P. mirabilis: CMY-2 5/230 (2.17%) Prevalence: 0.35% E. coli: 14/2956 (0.47%) CMY-2 13 (0.44%) CMYt 1 (0.03%) K. pneumoniae: DHA-1 + VIM-1 1/58 (1.72%) P. mirabilis: CMY-2 2/247 (0.81%) Prevalence: 0.62% E. coli: 13/4088 (0.32%) CMY-2 10 (0.24%) CMY-4 1 (0.02%) FOX-8 2 (0.05%) K. pneumoniae: CMY-2 1/357 (0.28%)